Temperature- and time-dependent changes in TLR2-activated microglial NF-κB activity and concentrations of

Tomohiro Matsui1, Moe Tasaki, Takahiro Yoshioka

  • 1Department of Laboratory Sciences, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan. giants@yamaguchi-u.ac.jp

Abstract

Insights

Therapeutic hypothermia reduces microglial production of TNF-α, IL-10, and NO by inhibiting NF-κB activation. This suggests a neuroprotective mechanism, with these factors potentially serving as clinical markers for hypothermia-related neuronal protection or injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Therapeutic hypothermia offers neuroprotection in central nervous system (CNS) injuries.
  • Microglia, immune cells in the CNS, express toll-like receptors (TLRs) involved in CNS injury pathology.
  • TLR2 activation in microglia can lead to the production of cytokines and nitric oxide (NO), contributing to CNS damage.

Purpose of the Study:

  • To investigate the impact of culture temperature on TLR2-activated microglial production of cytokines (TNF-α, IL-10) and NO.
  • To explore the role of nuclear factor-κB (NF-κB) activation in temperature-dependent microglial responses.
  • To determine potential neuroprotective mechanisms of therapeutic hypothermia related to microglial activation.

Main Methods:

  • Rat microglia were stimulated with a TLR2 agonist (Pam3CSK4) under hypothermic, normothermic, and hyperthermic conditions.
  • NF-κB activation was assessed, along with the production of TNF-α, IL-10, and NO.
  • Experiments were also conducted with an NF-κB activation inhibitor at 37°C to confirm pathway involvement.

Main Results:

  • Hypothermia significantly reduced the production of TNF-α, IL-10, and NO, as well as NF-κB p65 activation.
  • Hyperthermia conversely augmented the production of these inflammatory mediators and NF-κB activation.
  • Inhibition of NF-κB activation abolished Pam3CSK4-induced TNF-α, IL-10, and NO production, confirming NF-κB's central role.

Conclusions:

  • Hypothermia suppresses TLR2-mediated NF-κB activation and subsequent inflammatory mediator production in microglia, indicating a neuroprotective mechanism.
  • Hyperthermia exacerbates these responses, suggesting potential for neuronal injury.
  • Temperature-dependent changes in TNF-α, IL-10, and NO production may serve as clinical biomarkers for monitoring therapeutic hypothermia efficacy or hyperthermia-induced injury.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...